Articles

26 Jan 2007 Nippon Shinyaku, Apogepha Terminate Development of NS-8, for the Treatment of Overactive Bladder
25 Jan 2007 Merck Serono Has Initiated The Onward Study To Evaluate Oral Cladribine As Add-On Treatment For Multiple Sclerosis
25 Jan 2007 Lexicon Genetics Initiates Clinical Trials of LX1031 for Irritable Bowel Syndrome
25 Jan 2007 Obecure Recruits First Patient in Phase II Obesity Study
24 Jan 2007 Wyeth Receives Approvable Letter From FDA for Pristiq (Desvenlafaxine Succinate) for the Treatment of Major Depressive Disorder
24 Jan 2007 MediGene Initiates a Clinical Phase IIa Trial of RhuDex(R) in Rheumatoid Arthritis
24 Jan 2007 Astellas Receives an Action Letter from FDA for NDA of FK506 MR in the U.S.
24 Jan 2007 Fresenius Medical Care Announces FDA Submission of New Drug Application for PhosLo
24 Jan 2007 Pharmion Submits European Marketing Authorization Application for Thalidomide Pharmion(R) for Untreated Multiple Myeloma
24 Jan 2007 4SC nominates NFkB development candidate and presents new data
24 Jan 2007 Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
24 Jan 2007 Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
24 Jan 2007 New results from the ESPRIT trial confirm that dipyridamole plus aspirin is the treatment of choice for preventing recurrent stroke
24 Jan 2007 Stiefel Laboratories Receives FDA Approval Of Olux-E (Clobetasol Propionate) Foam, 0.05% For Treatment Of Psoriasis And Eczema
23 Jan 2007 Inovelon(R) recieves Marketing Authorization Approval from European Commission
23 Jan 2007 FDA Grants Chelsea Therapeutics Orphan Drug Designation for Droxidopa
23 Jan 2007 Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
23 Jan 2007 Sirion Therapeutics Initiates Enrollment of Phase III Clinical Trials for the Treatment of Inflammation Following Ocular Surgery
23 Jan 2007 Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor
23 Jan 2007 Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
23 Jan 2007 MediciNova Initiates Phase II Clinical Trial for MN-305, a Novel Treatment for Insomnia
20 Jan 2007 S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone
20 Jan 2007 Pharmos Corporation Announces Clinical Data From Phase 2a Trial Of Cannabinor For Capsaicin-induced Pain; Drug Ineffective In Trial
20 Jan 2007 Penwest Begins Next Study in Development of Nalbuphine ER
20 Jan 2007 Bionovo Launches Pharmacokinetics Trial of Its Lead Menopause Drug Candidate, MF101

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top